SCHEMBL22240686

SCHEMBL22240686

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4cc(-c5ccc6c(c5)sc5ccc(-c7cccc(-c8ccc9c%10ccccc%10c%10ccccc%10c9c8)c7)cc56)ccc4c3)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 1/20 0.36
ALDH1A1 P00352 4/20 0.35
MAPT P10636 3/20 0.35
HPGD P15428 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
RAB9A P51151 1/20 0.35
F9 P00740 2/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
LIMK1 P53667 3/20 0.34
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
CYP1A2 P05177 4/20 0.34
KDM4E B2RXH2 2/20 0.34
HSD17B10 Q99714 2/20 0.34
TP53 P04637 1/20 0.34
PIK3CA P42336 1/20 0.34
PI4KA P42356 1/20 0.34
PI4KB Q9UBF8 1/20 0.34
CYP3A4 P08684 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22352669 0.96 PIM3 (0.39) PIM3ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL23790469 0.96 PIM3 (0.39) PIM3ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL22240561 0.96 PIM3 (0.39) PIM3ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL23790569 0.96 PIM3 (0.39) PIM3ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL22240903 0.96 ADORA2A (0.37) ALDH1A1MAPTHPGDSMN1; SMN2RAB9A
SCHEMBL22352368 0.95 PIM3 (0.40) PIM3ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL22352362 0.95 ALDH1A1 (0.40) PIM3ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL22352370 0.95 PIM3 (0.40) PIM3ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL21755949 0.95 PIM3 (0.40) PIM3ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL22352262 0.95 ALDH1A1 (0.40) PIM3ALDH1A1MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11515484-B2 Heterocyclic compound and organic light emitting element comprising same LT MATERIALS CO., LTD. (KR) 2022-11-29 US disclosed
US-20200266355-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME HEESUNG MATERIAL LTD. (KR) 2020-08-20 US disclosed
EP-3683217-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LT Materials Co., Ltd. (KR) 2020-07-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11515484-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, CYP1A1 PIM3 2903/4885ALDH1A1 15/4885MAPT 1487/4885
US-20200266355-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, CYP1A1 PIM3 2903/4885ALDH1A1 15/4885MAPT 1487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.